NO307686B1 - Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter - Google Patents
Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletterInfo
- Publication number
- NO307686B1 NO307686B1 NO940008A NO940008A NO307686B1 NO 307686 B1 NO307686 B1 NO 307686B1 NO 940008 A NO940008 A NO 940008A NO 940008 A NO940008 A NO 940008A NO 307686 B1 NO307686 B1 NO 307686B1
- Authority
- NO
- Norway
- Prior art keywords
- tablet
- tablets
- preparation
- pharmaceutical tablet
- colestipol hydrochloride
- Prior art date
Links
- 229920002911 Colestipol Polymers 0.000 title abstract 2
- 229960002577 colestipol hydrochloride Drugs 0.000 title abstract 2
- GACQNVJDWUAPFY-UHFFFAOYSA-N n'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;hydrochloride Chemical compound Cl.NCCNCCNCCNCCN GACQNVJDWUAPFY-UHFFFAOYSA-N 0.000 title abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 229940069328 povidone Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72504491A | 1991-07-03 | 1991-07-03 | |
| PCT/US1992/005066 WO1993000915A1 (en) | 1991-07-03 | 1992-06-23 | Colestipol hydrochloride high-content tablets |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO940008L NO940008L (no) | 1994-01-03 |
| NO940008D0 NO940008D0 (no) | 1994-01-03 |
| NO307686B1 true NO307686B1 (no) | 2000-05-15 |
Family
ID=24912923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940008A NO307686B1 (no) | 1991-07-03 | 1994-01-03 | Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5490987A (pl) |
| EP (1) | EP0592594B1 (pl) |
| JP (1) | JP3313710B2 (pl) |
| KR (1) | KR100240362B1 (pl) |
| AT (1) | ATE173931T1 (pl) |
| AU (1) | AU669664B2 (pl) |
| CA (1) | CA2110166C (pl) |
| CZ (1) | CZ286958B6 (pl) |
| DE (1) | DE69227773T2 (pl) |
| DK (1) | DK0592594T3 (pl) |
| ES (1) | ES2124736T3 (pl) |
| FI (1) | FI106843B (pl) |
| HU (1) | HU222242B1 (pl) |
| NO (1) | NO307686B1 (pl) |
| PL (1) | PL169045B1 (pl) |
| RU (1) | RU2108090C1 (pl) |
| SK (1) | SK281920B6 (pl) |
| WO (1) | WO1993000915A1 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2129079C (en) * | 1993-08-03 | 2006-01-17 | Tatsuo Nomura | Orally administrable cholesterol lowering agent |
| NZ503086A (en) * | 1997-08-29 | 2002-03-01 | Upjohn Co | An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes |
| CN1202812C (zh) * | 1999-10-19 | 2005-05-25 | 基酶有限公司 | 直接压缩聚合物片剂核 |
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
| US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
| AU2004311849B2 (en) * | 2003-12-31 | 2009-04-02 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
| US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| WO2007027566A2 (en) | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
| CA2622693C (en) | 2005-09-15 | 2015-05-05 | Genzyme Corporation | Sachet formulation for amine polymers |
| WO2008062437A2 (en) * | 2006-09-01 | 2008-05-29 | Usv Limited | Process for the preparation of sevelamer hydrochloride and formulation thereof |
| US7964182B2 (en) * | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
| EP2066293A2 (en) | 2006-09-29 | 2009-06-10 | Genzyme Corporation | Amide dendrimer compositions |
| US8163799B2 (en) | 2006-12-14 | 2012-04-24 | Genzyme Corporation | Amido-amine polymer compositions |
| KR20110059750A (ko) * | 2008-09-02 | 2011-06-03 | 유에스브이 리미티드 | 가교 폴리머 |
| US20110081413A1 (en) * | 2009-01-22 | 2011-04-07 | Ashok Omray | Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| US9763928B2 (en) * | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| MA41202A (fr) | 2014-12-18 | 2017-10-24 | Genzyme Corp | Copolymères polydiallymine réticulé pour le traitement du diabète de type 2 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803237A (en) * | 1969-11-03 | 1974-04-09 | Upjohn Co | Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds |
| US3692895A (en) * | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
| ZA804914B (en) * | 1979-08-29 | 1981-08-26 | Rohm & Haas | The production of powdered resin and the powdered resin so produced |
| US4439419A (en) * | 1980-02-20 | 1984-03-27 | The Upjohn Company | Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin |
| US4404346A (en) * | 1980-08-05 | 1983-09-13 | Rohm And Haas Company | Production of powdered resin and the powdered resin so produced |
| US4631305A (en) * | 1985-03-22 | 1986-12-23 | The Upjohn Company | Polymeric material as a disintegrant in a compressed tablet |
| CS255081B1 (cs) * | 1985-12-21 | 1988-02-15 | Arnost Pospisil | Způsob Výroby tablet s časové řízenou liberací obsahující nestálou a/nabo dráidivou fyziologicky aktivní složku |
| IE63242B1 (en) * | 1988-06-24 | 1995-04-05 | Abbott Lab | Pharmaceutical granules and tablets made therefrom |
| DE68907721T2 (de) * | 1988-06-24 | 1993-11-18 | Upjohn Co | Feingemahlenes colestipol-hydrochlorid. |
| AU628389B2 (en) * | 1988-08-26 | 1992-09-17 | Pharmacia & Upjohn Company | Fine-beaded colestipol hydrochloride |
-
1992
- 1992-06-23 ES ES92915578T patent/ES2124736T3/es not_active Expired - Lifetime
- 1992-06-23 CZ CZ19932826A patent/CZ286958B6/cs not_active IP Right Cessation
- 1992-06-23 EP EP92915578A patent/EP0592594B1/en not_active Expired - Lifetime
- 1992-06-23 SK SK1-94A patent/SK281920B6/sk not_active IP Right Cessation
- 1992-06-23 AT AT92915578T patent/ATE173931T1/de active
- 1992-06-23 DK DK92915578T patent/DK0592594T3/da active
- 1992-06-23 PL PL92301951A patent/PL169045B1/pl unknown
- 1992-06-23 AU AU22933/92A patent/AU669664B2/en not_active Expired
- 1992-06-23 DE DE69227773T patent/DE69227773T2/de not_active Expired - Lifetime
- 1992-06-23 JP JP50222193A patent/JP3313710B2/ja not_active Expired - Lifetime
- 1992-06-23 HU HU9400004A patent/HU222242B1/hu active IP Right Grant
- 1992-06-23 US US08/175,412 patent/US5490987A/en not_active Expired - Lifetime
- 1992-06-23 CA CA002110166A patent/CA2110166C/en not_active Expired - Lifetime
- 1992-06-23 KR KR1019930704111A patent/KR100240362B1/ko not_active Expired - Lifetime
- 1992-06-23 RU RU93058535A patent/RU2108090C1/ru active
- 1992-06-23 WO PCT/US1992/005066 patent/WO1993000915A1/en not_active Ceased
-
1993
- 1993-12-30 FI FI935943A patent/FI106843B/fi not_active IP Right Cessation
-
1994
- 1994-01-03 NO NO940008A patent/NO307686B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69227773T2 (de) | 1999-05-20 |
| PL169045B1 (pl) | 1996-05-31 |
| ES2124736T3 (es) | 1999-02-16 |
| RU2108090C1 (ru) | 1998-04-10 |
| FI935943A0 (fi) | 1993-12-30 |
| NO940008L (no) | 1994-01-03 |
| NO940008D0 (no) | 1994-01-03 |
| AU2293392A (en) | 1993-02-11 |
| CA2110166C (en) | 2002-11-05 |
| EP0592594A1 (en) | 1994-04-20 |
| HU222242B1 (hu) | 2003-05-28 |
| DK0592594T3 (da) | 1999-08-16 |
| SK281920B6 (sk) | 2001-09-11 |
| JP3313710B2 (ja) | 2002-08-12 |
| HUT69394A (en) | 1995-09-28 |
| US5490987A (en) | 1996-02-13 |
| AU669664B2 (en) | 1996-06-20 |
| CA2110166A1 (en) | 1993-01-21 |
| CZ282693A3 (en) | 1994-06-15 |
| FI106843B (fi) | 2001-04-30 |
| FI935943L (fi) | 1993-12-30 |
| EP0592594B1 (en) | 1998-12-02 |
| HU9400004D0 (en) | 1994-05-30 |
| CZ286958B6 (cs) | 2000-08-16 |
| ATE173931T1 (de) | 1998-12-15 |
| WO1993000915A1 (en) | 1993-01-21 |
| SK194A3 (en) | 1994-11-09 |
| JPH06509097A (ja) | 1994-10-13 |
| DE69227773D1 (de) | 1999-01-14 |
| KR100240362B1 (ko) | 2000-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO940008L (no) | Tablettering av colestipolhydroklorid | |
| MX9500243A (es) | Composicion de liberacion acelerada que contiene bromocriptina. | |
| EP0396404A1 (en) | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine | |
| CA2106172A1 (en) | Use of 2-(3,4-Dimethoxycinnamoyl)Aminobenzoic Acid for the Treatment of Restenosis Associated with Coronary Intervention | |
| NO942325L (no) | Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse | |
| NO923859L (no) | Medikament | |
| BR9709838A (pt) | Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase | |
| MX173567B (es) | Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih | |
| NO962752L (no) | Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose | |
| NO308644B1 (no) | Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat | |
| NO933321L (no) | NADH og NADPH som legemiddel til behandling av Mobus Alzheimer | |
| EP0552057A1 (en) | Azauridine compounds in the treatment of rheumatoid arthritis | |
| Plante et al. | Dipyridamole-aspirin versus low doses of heparin in the prophylaxis of deep venous thrombosis in abdominal surgery | |
| US3803304A (en) | Orally administratable pancreatic enzymes and methods of using same | |
| KR950013513A (ko) | 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 | |
| ES2042831T3 (es) | Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis. | |
| Pitkeathly et al. | Indomethacin in in-patient treatment of rheumatoid arthritis | |
| YU56702A (sh) | Korišćenje fsh za lečenje neplodnosti | |
| Ockelford et al. | A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (Fragmin) in patients having major elective general surgery | |
| GB2174004A (en) | Effervescent tablets | |
| CA2184361C (en) | Solid dose forms containing bismuth | |
| EP0681476B1 (en) | Unit dose form of bismuth subsalicylate | |
| US4522827A (en) | Method of treating acute pancreatitis with isometheptene | |
| Segal et al. | A polyamine formaldehyde resin IV. Clinical evaluation in the treatment of duodenal ulcer | |
| US5081129A (en) | Method of treatment of anemia with seratonin antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |